Overview
Announcements

Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 8th January 2024

In the ordinary rebalance, the following composition will be implemented effective open 08.01.2024:

ABBOTT LABORATORIES
ABBVIE INC
ALCON INC
AMEDISYS INC
AMGEN INC
BECTON DICKINSON AND CO
BIOGEN INC
BRISTOL-MYERS SQUIBB CO
CENTENE CORP
COLOPLAST AS CLASS B
CONVATEC GROUP PLC
COOPER COMPANIES INC
DANAHER CORP
ELEVANCE HEALTH INC
ENCOMPASS HEALTH CORP
ENSIGN GROUP INC
ESSILORLUXOTTICA
GETINGE AB CLASS B
GILEAD SCIENCES INC
GSK PLC
HOLOGIC INC
HUMANA INC
IQVIA HOLDINGS INC
JOHNSON & JOHNSON
LABORATORY CRP OF AMER HLDGS
MEDTRONIC PLC
MERCK & CO. INC.
MOLINA HEALTHCARE INC
NEUROCRINE BIOSCIENCES INC
NOVARTIS AG
PFIZER INC
PRESTIGE CONSUMER HEALTHCARE INC
QIAGEN NV
QUEST DIAGNOSTICS INC
RECORDATI SPA
REGENERON PHARMACEUTICALS
ROCHE HOLDING AG
ROYALTY PHARMA PLC- CL A
SIEMENS HEALTHINEERS AG
SONOVA HOLDING AG
STERIS PLC
STRYKER CORP
SWEDISH ORPHAN BIOVITRUM AB
THERMO FISHER SCIENTIFIC INC
UCB SA
UNITED THERAPEUTICS CORP
UNITEDHEALTH GROUP INC
VIATRIS INC
ZIMMER BIOMET HOLDINGS INC
ZOETIS INC